烯,陈诺二氧化酸和乌尔索二氧化酸对常见胆道结石复发和胆囊结石溶解的组合作用
Min Je Sung1, Sung Yong Han2, Jong Hyun Lee2
1Digestive Disease Center, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13496, Republic of Korea.
Journal of clinical medicine
|December 17, 2024
概括
与单个药物或不服用药物相比,结合陈二氧化醇酸 (CDCA) 加上乌尔二氧化醇酸 (UDCA) 和二烯的双剂疗法显著减少了普通胆道 (CBD) 石头的复发,并改善了胆囊 (GB) 石头的分辨率.
科学领域:
- 肝病学和胃肠病学 肝病学和胃肠学
- 胆道疾病 胆道疾病
- 药理干预药理干预
背景情况:
- 常见的胆管 (CBD) 石头的复发和胆囊 (GB) 石头的持续是内镜逆行胆管瘤学 (ERCP) 后的临床挑战.
- 乌尔索多氧化酸 (UDCA),陈诺多氧化酸 (CDCA) 加上UDCA (C&U) 和是治疗胆道结石的医学疗法.
研究的目的:
- 评估和比较单剂和双剂疗法在预防CBD石头复发方面的疗效.
- 评估这些药物的有效性,以实现ERCP后的GB石头解决.
主要方法:
- 在六个转诊中心对940名CBD石头复发患者和98名GB石头解决患者的回顾性分析.
- 患者被分为无药,单剂 (UDCA,C&U,或) 或双剂 (加UDCA或C&U) 治疗组.
- 评估涉及ERCP,胆囊切除术和6个月的随访期间的超声波.
主要成果:
- 双剂疗法显著降低了CBD石头复发率 (9.8%),与没有药物 (41.5%) 和单剂 (12.7%) 相比 (p < 0.001).
- 在CBD复发队列中,C&U加上烯的组合显示出最低的复发率 (5.2%) (p = 0.002).
- 在双剂组 (34.8%) 与单剂组 (14.3%) 和无药 (5.3%) 组 (p = 0.028) 中,GB石块分辨率显著更高.
结论:
- 结合C&U加上烯的组合在预防CBD石头复发方面表现出卓越的疗效.
- 双剂疗法,特别是C&U加上烯,对于实现GB石的分离,比单剂疗法或不使用药物更有效.
相关概念视频
Hepatic Drug Excretion: Influencing Factors
80
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
80
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Hepatic Drug Excretion: Enterohepatic Cycling
996
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
996
Chronic Bowel Disorders: Introduction
386
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
386
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
174
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
174
Endoscopic Procedures V: ERCP
83
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
83


